Pacira BioSciences (PCRX) Earnings Date, Estimates & Call Transcripts → Healthcare Takes A Big Step Forward With The Help Of AI (From The Bull Report) (Ad) Free pcrx Stock Alerts $26.10 -0.15 (-0.57%) (As of 04/22/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateMay. 1EstimatedActual EPS (Feb. 29) $0.71 Consensus EPS (Feb. 29) $0.71 Get Pacira BioSciences Earnings AlertsEnter your email address below to receive the latest news and earnings results for PCRX and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenuePCRX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.PCRX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Banyan Hill PublishingThe Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him Pacira BioSciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20242$0.38$0.53$0.46 Q2 20242$0.51$0.62$0.57 Q3 20242$0.46$0.59$0.53 Q4 20242$0.62$0.73$0.68 FY 20248$1.97$2.47$2.22 Q1 20251$0.69$0.69$0.69 Q2 20251$0.76$0.76$0.76 Q3 20251$0.72$0.72$0.72 Q4 20251$0.91$0.91$0.91 FY 20254$3.08$3.08 $3.08PCRX Earnings Date and InformationPacira BioSciences last issued its earnings data on February 29th, 2024. The reported $0.71 EPS for the quarter, hitting analysts' consensus estimates of $0.71. The firm had revenue of $181.24 million for the quarter, compared to analyst estimates of $180.60 million. Pacira BioSciences has generated $0.81 earnings per share over the last year ($0.81 diluted earnings per share) and currently has a price-to-earnings ratio of 32.2. Earnings for Pacira BioSciences are expected to grow by 29.82% in the coming year, from $2.18 to $2.83 per share. Pacira BioSciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 1st, 2024 based off prior year's report dates.Read More Pacira BioSciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/1/2024Estimated)------- 2/29/2024Q4 2023$0.71$0.71-$0.92$180.60 million$181.24 million11/2/2023Q3 2023$0.65$0.52($0.13)$0.81$172.83 million$163.93 million8/2/2023Q2 2023$0.59$0.61+$0.02$0.71$175.64 million$169.47 million5/3/2023Q1 2023$0.40$0.32($0.08)$1.07$157.02 million$160.34 million2/28/2023Q4 2022$0.71$0.60($0.11)$1.42$174.12 million$171.96 million11/3/2022Q3 2022$0.40$0.42+$0.02$0.86$167.30 million$167.47 million Get the Latest News and Ratings for PCRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pacira BioSciences and its competitors with MarketBeat's FREE daily newsletter. 8/3/2022Q2 2022$0.57$0.34($0.23)$0.28$169.27 million$169.41 million 5/4/2022Q1 2022$0.49$0.45($0.04)$0.75$155.08 million$157.99 million 2/24/2022Q4 2021$0.60$0.78+$0.18$1.68$157.42 million$159.19 million 11/2/2021Q3 2021$0.65$0.72+$0.07$0.67$129.69 million$127.70 million 8/2/2021Q2 2021$0.74$0.77+$0.03$0.78$135.02 million$135.60 million 5/3/2021Q1 2021$0.64$0.53($0.11)$0.51$119.23 million$119.00 million Pacira BioSciences Earnings - Frequently Asked Questions When is Pacira BioSciences's earnings date? Pacira BioSciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 1st, 2024 based off last year's report dates. Learn more on PCRX's earnings history. Did Pacira BioSciences beat their earnings estimates last quarter? In the previous quarter, Pacira BioSciences (NASDAQ:PCRX) reported $0.71 earnings per share (EPS) to hit the analysts' consensus estimate of $0.71. Learn more on analysts' earnings estimate vs. PCRX's actual earnings. How much revenue does Pacira BioSciences generate each year? Pacira BioSciences (NASDAQ:PCRX) has a recorded annual revenue of $674.98 million. How much profit does Pacira BioSciences generate each year? Pacira BioSciences (NASDAQ:PCRX) has a recorded net income of $41.96 million. PCRX has generated $0.81 earnings per share over the last four quarters. What is Pacira BioSciences's price-to-earnings ratio? Pacira BioSciences (NASDAQ:PCRX) has a trailing price-to-earnings ratio of 32.22 and a forward price-to-earnings ratio of 11.97. What is Pacira BioSciences's EPS forecast for next year? Pacira BioSciences's earnings are expected to grow from $2.18 per share to $2.83 per share in the next year, which is a 29.82% increase. More Earnings Resources from MarketBeat Related Companies: Supernus Pharmaceuticals Earnings OPKO Health Earnings ALX Oncology Earnings ADC Therapeutics Earnings Atea Pharmaceuticals Earnings Nektar Therapeutics Earnings Seres Therapeutics Earnings Corcept Therapeutics Earnings Alkermes Earnings Perrigo Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Taiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted Applied Optoelectronics earnings dumper, pain now for gain later? This page (NASDAQ:PCRX) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishingtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pacira BioSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
